The international recognition of our company is earned by its extraordinary product-innovation. The annual reports of the Hungarian Patent Office highlight the growing number of patents. Our range is widened by 1000 products every year. Our innovation power is proven by the National Quality Award, National Innovation Award, Hungarian Quality Product Award, The Most Dynamically Developing Small and Medium Enterprise of the Region Award, the Innovation Grand Award 2014 and the Hungarian Intellectual Property Office Innovation Award 2014.
We continuously cooperate with medical professors of Hungarian clinics (SOTE, SZOTE, POTE, DEOEC) combining the innovative ideas and their skills with the technical support of Universities and Institutes of Technology. We are systematically looking for the ideas of surgeons and nurses, summarizing the requirements of the three world-leading companies and supporting life quality improvement by advanced solutions. For achieving this, we keep our prices on a reasonable level and ensure that our systems and innovations are available for all users.
The equity capital of our company is more than 9,3 million EUR, having 225 employees. Progress and stability are reflected by the fact that our revenue grew by 10% from 2014 to 2015. Our value-added figure is 1,4 billion HUF. Based on this index we have been the 15th of the Top 50 companies in Heves region for several years. For the sake of innovation success we spent 5,3% of our income on Research & Development in 2015.
We are working together with several suppliers of the region (primarily tool supply, coolant-lubricating fluid supply, wagework and manufacturing aids in cooperation, machine maintenance, test laboratories, event management and other services) for whom the development of Sanatmetal is an outstanding opportunity to grow.
The quality of the products is guaranteed not only by the material and physical parameters but the design, manufacturing and quality management according to harmonized European Union legal regulations (ISO 9001:2000, ISO 13485:2003, ISO 14001:2005). Our notified body is BRITISH STANDARDS INSTITUTION and EMKI
66% of our income comes from export, our company is present in 35 countries in the American, Asian, European, Arabic and the CIS regions. In Hungary our company is market leader.
In company development we are on the way of becoming international, building our own distributor network (SM-Germany, SM-CIS, SM-Romania, SM-Turkey).
Our company is the recognized member of the field behind the multinational companies, our products are competed in international exhibitions (AAOS – USA, EFORT, Arab Health – Dubai, ESTES) and several national congresses (Russia, China, Germany, etc.)..
The recognition of our company is indicated by the fact that we are strategic supplier of the three multinational companies of the top five market-leader global ones in orthopedics and traumatology.
We were always looking for opportunities about how to make people’s life better and easier. That’s why when we came across an excellent idea, we embraced it. Based upon 30 years of research results and our decades of experience as medical equipment manufacterer, we made WIWE a reality.
The division of diagnostic devices is new to us, even so we threw ourselves into it with huge energy and enthusiasm. Our goal wasn’t the producing of just one product. We intended to make such home diagnostics tools, which purpose is to remind us to take care of our and our loved ones' health in today’s world.
Development of WIWE took approximately 2 years and the research behind the algorithm that was conducted by Professor George Kozmann and a team from Pannon University took three decades.
Besides SOTE, The Heart and Vascular Center of Semmelweis University, WIWE is also available in private hospitals, Apple stores, therapeutics stores and webstores. GPs, medical universities, cardiology and medicine departments have been using the device too.
Our main goal was, however, to create something useful for individual users: we regularly get thank you letters from people saying that WIWE helped diagnose their problem or adjust the right dose of their medication.
The registration and sale of the device has started so far in 20 countries. Recently, we have got the approval of the Australian Authority (TGA) to trade and begin the shipment of the pre-orders. Getting the FDA approval for the USA is expected by the end of the year.
The Chinese distribution has started with a minister-level cooperation that was signed by 16 Middle-East European countries and China’s medical minister in June during „The Gate of Health” congress.